Here’s whether MetLife, Inc. (MET) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive). Concerns: 50-day MA is falling (-0.69% over 10 days); RSI 88 — overbought, elevated pullback risk. Currently 6.9% off its 52-week high. Score: +1/7.
MET is in a confirmed uptrend, trading above both its 50-day ($73.23) and 200-day ($77.39) moving averages. With an RSI of 87.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +8.9% compares to +35.1% for SPY (trailed the market by 26.2%).
$10,000 invested 1 year ago→ $10,890 today
vs. S&P 500 (SPY) — same period trailed market by 26.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($77.39)
✓Above 50-day MA ($73.23)
!RSI(14) neutral zone (30–70) — currently 87.9
✓Positive return (+8.9%)
✓Within 10% of period high (−6.9%)
Period Range $78.08
$67.33$83.85
RSI (14) 87.9
0 · OversoldOverbought · 100
Key Metrics
Price$78.08
Period Return+8.9%
Period High$83.85
Period Low$67.33
Drawdown−6.9%
MA-50$73.23
MA-200$77.39
RSI (14)87.9
Avg Volume (30d)3.8M
vs. SPYtrailed by 26.2%
Return Rank#628 of 996
Trend Signals
Price is above the 200-day moving average ($77.39)